Eyebright Medical's Loong Crystal PR IOL received Class III certification from China's NMPA, indicating high regulatory ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration and Astellas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback